{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:58:44Z","timestamp":1780984724101,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,8]]},"DOI":"10.7759\/cureus.110497","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:16:27Z","timestamp":1780982187000},"source":"Crossref","is-referenced-by-count":0,"title":["Medications and Supplements Associated With Drug-Induced Glaucoma"],"prefix":"10.7759","author":[{"given":"Tarek","family":"Hammadieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Istanaksai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Jama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalla","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eesa","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidar","family":"Bilal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2011.128","article-title":"Non-steroidal drug-induced glaucoma","volume":"25","author":"Razeghinejad MR","year":"2011","unstructured":"Razeghinejad MR, Pro MJ, Katz LJ. Non-steroidal drug-induced glaucoma. Eye (Lond). 2011, 25:971-80. 10.1038\/eye.2011.128","journal-title":"Eye (Lond)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham YC","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014, 121:2081-90. 10.1016\/j.ophtha.2014.05.013","journal-title":"Ophthalmology"},{"key":"ref3","article-title":"Open angle glaucoma","author":"Tripathy K","year":"2024","unstructured":"Tripathy K, Zeppieri M. Open angle glaucoma. Ferri\u2019s Clinical Advisor 2025: 5 Books in 1. 2024. e21-473.e23."},{"key":"ref4","unstructured":"Glaucoma. Accessed. June 1, 2026: https:\/\/cks.nice.org.uk\/topics\/glaucoma\/background-information\/risk-factors\/."},{"key":"ref5","unstructured":"National Institutes of Health. Accessed. June 1, 2026: https:\/\/pmc.ncbi.nlm.nih.gov\/."},{"key":"ref6","unstructured":"Primary vs. Secondary angle closure glaucoma. Accessed. June 1, 2026: https:\/\/eyewiki.org\/Primary_vs._Secondary_Angle_Closure_Glaucoma."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e32808738d5","article-title":"Drug-induced acute angle closure glaucoma","volume":"18","author":"Lachkar Y","year":"2007","unstructured":"Lachkar Y, Bouassida W. Drug-induced acute angle closure glaucoma. Curr Opin Ophthalmol. 2007, 18:129-33. 10.1097\/ICU.0b013e32808738d5","journal-title":"Curr Opin Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1017\/9781108776936.043","article-title":"Corticosteroids","author":"Shulman R","year":"2020","unstructured":"Shulman R. Corticosteroids. Surviving Prescribing: A Practical Guide, Second Edition. Montgomery H, Shulman R, Murali M (ed): Cambridge University Press, 2020. 199-200. 10.1017\/9781108776936.043"},{"key":"ref9","article-title":"Steroid-induced glaucoma","author":"Feroze K","year":"2026","unstructured":"Feroze K, Zeppieri M, Khazaeni L. Steroid-induced glaucoma. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2026."},{"key":"ref10","article-title":"Steroids: pharmacology, complications, and practice delivery issues","volume":"14","author":"Ericson-Neilsen W","year":"2014","unstructured":"Ericson-Neilsen W, Kaye AD. Steroids: pharmacology, complications, and practice delivery issues. Ochsner J. 2014, 14:203-7.","journal-title":"Ochsner J"},{"key":"ref11","article-title":"Expression profile analysis to identify potential gene changes induced by dexamethasone in the trabecular meshwork","volume":"15","author":"Wei M","year":"2022","unstructured":"Wei M, Chen LM, Huang ZY, Zhang GW, Guan HJ, Ji M. Expression profile analysis to identify potential gene changes induced by dexamethasone in the trabecular meshwork. Int J Ophthalmol. 2022, 15:1240-8.","journal-title":"Int J Ophthalmol"},{"key":"ref12","unstructured":"Steroid-induced glaucoma. Accessed. June 1, 2026: https:\/\/eyewiki.org\/Steroid-Induced_Glaucoma."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-14429","article-title":"Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice","volume":"55","author":"Overby DR","year":"2014","unstructured":"Overby DR, Bertrand J, Tektas OY, et al.. Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice. Invest Ophthalmol Vis Sci. 2014, 55:4922-33. 10.1167\/iovs.14-14429","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1963.00960050502012","article-title":"Corticosteroids and intraocular pressure","volume":"70","author":"Becker B","year":"1963","unstructured":"Becker B, Mills DW. Corticosteroids and intraocular pressure. Arch Ophthalmol. 1963, 70:500-7. 10.1001\/archopht.1963.00960050502012","journal-title":"Arch Ophthalmol"},{"key":"ref15","article-title":"Corticosteroid glaucoma","volume":"9","author":"Fran\u00e7ois J","year":"1977","unstructured":"Fran\u00e7ois J. Corticosteroid glaucoma. Ann Ophthalmol. 1977, 9:1075-80.","journal-title":"Ann Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.11.017","article-title":"Pharmaceutical and medicinal significance of sulfur (S(VI))-containing motifs for drug discovery: a critical review","volume":"162","author":"Zhao C","year":"2019","unstructured":"Zhao C, Rakesh KP, Ravidar L, Fang WY, Qin HL. Pharmaceutical and medicinal significance of sulfur (S(VI))-containing motifs for drug discovery: a critical review. Eur J Med Chem. 2019, 162:679-734. 10.1016\/j.ejmech.2018.11.017","journal-title":"Eur J Med Chem"},{"key":"ref17","article-title":"A short review on: sulphonamides","volume":"4","author":"Pareek A","year":"2013","unstructured":"Pareek A, Rani P, Kishore AD. A short review on: sulphonamides. Int J Pharm Bio Sci. 2013, 4:812-20.","journal-title":"Int J Pharm Bio Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10078-1261","article-title":"Drug-induced acute angle-closure glaucoma: a review","volume":"13","author":"Yang MC","year":"2019","unstructured":"Yang MC, Lin KY. Drug-induced acute angle-closure glaucoma: a review. J Curr Glaucoma Pract. 2019, 13:104-9. 10.5005\/jp-journals-10078-1261","journal-title":"J Curr Glaucoma Pract"},{"key":"ref19","article-title":"Case reports and small case series: topiramate-induced acute myopia and retinal striae","volume":"119","author":"Sen HA","year":"2001","unstructured":"Sen HA, O'Halloran HS, Lee WB. Case reports and small case series: topiramate-induced acute myopia and retinal striae. Arch Ophthalmol. 2001, 119:775-7.","journal-title":"Arch Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00774-8","article-title":"Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma","volume":"137","author":"Craig JE","year":"2004","unstructured":"Craig JE, Ong TJ, Louis DL, Wells JM. Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma. Am J Ophthalmol. 2004, 137:193-5. 10.1016\/S0002-9394(03)00774-8","journal-title":"Am J Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-14-96","article-title":"Acute myopia and angle closure glaucoma from topiramate in a seven-year-old: a case report and review of the literature","volume":"14","author":"Rapoport Y","year":"2014","unstructured":"Rapoport Y, Benegas N, Kuchtey RW, Joos KM. Acute myopia and angle closure glaucoma from topiramate in a seven-year-old: a case report and review of the literature. BMC Pediatr. 2014, 14:96. 10.1186\/1471-2431-14-96","journal-title":"BMC Pediatr"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-006509","article-title":"Topiramate-induced refractive change and angle closure glaucoma and its ultrasound bimicroscopy findings","volume":"2012","author":"Saffra N","year":"2012","unstructured":"Saffra N, Smith SN, Seidman CJ. Topiramate-induced refractive change and angle closure glaucoma and its ultrasound bimicroscopy findings. BMJ Case Rep. 2012, 2012:10.1136\/bcr-2012-006509","journal-title":"BMJ Case Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S38324","article-title":"Acetazolamide-induced cilio-choroidal effusion after cataract surgery: unusual posterior involvement","volume":"7","author":"Malagola R","year":"2013","unstructured":"Malagola R, Arrico L, Giannotti R, Pattavina L. Acetazolamide-induced cilio-choroidal effusion after cataract surgery: unusual posterior involvement. Drug Des Devel Ther. 2013, 7:33-6. 10.2147\/DDDT.S38324","journal-title":"Drug Des Devel Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S41540","article-title":"Acute bilateral angle closure glaucoma induced by methazolamide","volume":"7","author":"Aref AA","year":"2013","unstructured":"Aref AA, Sayyad FE, Ayres B, Lee RK. Acute bilateral angle closure glaucoma induced by methazolamide. Clin Ophthalmol. 2013, 7:279-82. 10.2147\/OPTH.S41540","journal-title":"Clin Ophthalmol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0603-z","article-title":"A review of systemic medications that may modulate the risk of glaucoma","volume":"34","author":"Wu A","year":"2020","unstructured":"Wu A, Khawaja AP, Pasquale LR, Stein JD. A review of systemic medications that may modulate the risk of glaucoma. Eye (Lond). 2020, 34:12-28. 10.1038\/s41433-019-0603-z","journal-title":"Eye (Lond)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e318098739b","article-title":"Choroidal drainage in the management of acute angle closure after topiramate toxicity","volume":"16","author":"Parikh R","year":"2007","unstructured":"Parikh R, Parikh S, Das S, Thomas R. Choroidal drainage in the management of acute angle closure after topiramate toxicity. J Glaucoma. 2007, 16:691-3. 10.1097\/IJG.0b013e318098739b","journal-title":"J Glaucoma"},{"key":"ref27","article-title":"Anticholinergic medications","author":"Ghossein N","year":"2026","unstructured":"Ghossein N, Kang M, Lakhkar AD. Anticholinergic medications. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2026."},{"key":"ref28","article-title":"Risk of acute angle-closure glaucoma after diagnostic mydriasis in nonselected subjects: the Rotterdam Study","volume":"38","author":"Wolfs RC","year":"1997","unstructured":"Wolfs RC, Grobbee DE, Hofman A, de Jong PT. Risk of acute angle-closure glaucoma after diagnostic mydriasis in nonselected subjects: the Rotterdam Study. Invest Ophthalmol Vis Sci. 1997, 38:2683-7.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.304.6818.40","article-title":"Acute angle closure glaucoma associated with nebulised ipratropium bromide and salbutamol","volume":"304","author":"Shah P","year":"1992","unstructured":"Shah P, Dhurjon L, Metcalfe T, Gibson JM. Acute angle closure glaucoma associated with nebulised ipratropium bromide and salbutamol. BMJ. 1992, 304:40-1. 10.1136\/bmj.304.6818.40","journal-title":"BMJ"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4103\/tjo.tjo_41_17","article-title":"Acute angle closure following periorbital botulinum toxin injection in a patient with retinitis pigmentosa","volume":"7","author":"Tsai JC","year":"2017","unstructured":"Tsai JC. Acute angle closure following periorbital botulinum toxin injection in a patient with retinitis pigmentosa. Taiwan J Ophthalmol. 2017, 7:104-7. 10.4103\/tjo.tjo_41_17","journal-title":"Taiwan J Ophthalmol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.4103\/0974-9233.110620","article-title":"Glycopyrrolate induced bilateral angle closure glaucoma after cervical spine surgery","volume":"20","author":"Jaroudi M","year":"2013","unstructured":"Jaroudi M, Fadi M, Farah F, El Mollayess GM. Glycopyrrolate induced bilateral angle closure glaucoma after cervical spine surgery. Middle East Afr J Ophthalmol. 2013, 20:182-4. 10.4103\/0974-9233.110620","journal-title":"Middle East Afr J Ophthalmol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2018.09.006","article-title":"Association between serotonin-norepinephrine reuptake inhibitors and acute angle closure: what is known?","volume":"64","author":"Wici\u0144ski M","year":"2019","unstructured":"Wici\u0144ski M, Kaluzny BJ, Liberski S, Marczak D, Seredyka-Burduk M, Pawlak-Osi\u0144ska K. Association between serotonin-norepinephrine reuptake inhibitors and acute angle closure: what is known?. Surv Ophthalmol. 2019, 64:185-94. 10.1016\/j.survophthal.2018.09.006","journal-title":"Surv Ophthalmol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15m10038","article-title":"Association of selective serotonin reuptake inhibitor use and acute angle-closure glaucoma","volume":"77","author":"Chen HY","year":"2016","unstructured":"Chen HY, Lin CL, Lai SW, Kao CH. Association of selective serotonin reuptake inhibitor use and acute angle-closure glaucoma. J Clin Psychiatry. 2016, 77:e692-6. 10.4088\/JCP.15m10038","journal-title":"J Clin Psychiatry"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123682","article-title":"Bupropion use and risk of open-angle glaucoma among enrollees in a large U.S. managed care network","volume":"10","author":"Stein JD","year":"2015","unstructured":"Stein JD, Talwar N, Kang JH, Okereke OI, Wiggs JL, Pasquale LR. Bupropion use and risk of open-angle glaucoma among enrollees in a large U.S. managed care network. PLoS ONE. 2015, 10:e0123682. 10.1371\/journal.pone.0123682","journal-title":"PLoS ONE"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2005.tb06613.x","article-title":"Bilateral acute angle closure caused by supraciliary effusions associated with venlafaxine intake","volume":"182","author":"de Guzman MH","year":"2005","unstructured":"de Guzman MH, Thiagalingam S, Ong PY, Goldberg I. Bilateral acute angle closure caused by supraciliary effusions associated with venlafaxine intake. Med J Aust. 2005, 182:121-3. 10.5694\/j.1326-5377.2005.tb06613.x","journal-title":"Med J Aust"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.107185","article-title":"Bilateral symptomatic angle closure associated with a regular dose of citalopram, an SSRI antidepressant","volume":"91","author":"Massaoutis P","year":"2007","unstructured":"Massaoutis P, Goh D, Foster PJ. Bilateral symptomatic angle closure associated with a regular dose of citalopram, an SSRI antidepressant. Br J Ophthalmol. 2007, 91:1086-7. 10.1136\/bjo.2006.107185","journal-title":"Br J Ophthalmol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-5-23","article-title":"Citalopram associated with acute angle-closure glaucoma: case report","volume":"5","author":"Croos R","year":"2005","unstructured":"Croos R, Thirumalai S, Hassan S, Davis Jda R. Citalopram associated with acute angle-closure glaucoma: case report. BMC Ophthalmol. 2005, 5:23. 10.1186\/1471-2415-5-23","journal-title":"BMC Ophthalmol"},{"key":"ref38","article-title":"Cholinergic medications","author":"Pakala RS","year":"2026","unstructured":"Pakala RS, Brown KN, Preuss CV. Cholinergic medications. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2026."},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.73690","article-title":"Management of angle closure glaucoma","volume":"59","author":"See JL","year":"2011","unstructured":"See JL, Aquino MC, Aduan J, Chew PT. Management of angle closure glaucoma. Indian J Ophthalmol. 2011, 59:S82-7. 10.4103\/0301-4738.73690","journal-title":"Indian J Ophthalmol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-02394-8.X0001-0","article-title":"Becker-Shaffer\u2019s Diagnosis and Therapy of the Glaucomas: Eighth Edition","author":"Stamper RL","year":"2009","unstructured":"Stamper RL, Lieberman MF, Drake MV. Becker-Shaffer\u2019s Diagnosis and Therapy of the Glaucomas: Eighth Edition. 2009. 10.1016\/B978-0-323-02394-8.X0001-0"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.01.2012.5694","article-title":"Pilocarpine induced acute angle closure","volume":"2012","author":"Day AC","year":"2012","unstructured":"Day AC, Nolan W, Malik AN, Viswanathan AC, Foster PJ. Pilocarpine induced acute angle closure. BMJ Case Rep. 2012, 2012:10.1136\/bcr.01.2012.5694","journal-title":"BMJ Case Rep"},{"key":"ref42","article-title":"In brief: what are anticoagulants?","year":"2006","unstructured":"In brief. what are anticoagulants?. InformedHealth.org [Internet]. Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany; 2006."},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(98)00101-9","article-title":"Bilateral secondary angle-closure glaucoma as a complication of anticoagulation in a nanophthalmic patient","volume":"1","author":"Caronia RM","year":"1998","unstructured":"Caronia RM, Sturm RT, Fastenberg DM, Berke SJ, Weintraub J. Bilateral secondary angle-closure glaucoma as a complication of anticoagulation in a nanophthalmic patient. Am J Ophthalmol. 1998, 1:307-9. 10.1016\/S0002-9394(98)00101-9","journal-title":"Am J Ophthalmol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-018-0857-4","article-title":"A rare case of acute angle closure due to spontaneous suprachoroidal haemorrhage secondary to loss of anti-coagulation control: a case report","volume":"18","author":"Masri I","year":"2018","unstructured":"Masri I, Smith JM, Wride NK, Ghosh S. A rare case of acute angle closure due to spontaneous suprachoroidal haemorrhage secondary to loss of anti-coagulation control: a case report. BMC Ophthalmol. 2018, 18:224. 10.1186\/s12886-018-0857-4","journal-title":"BMC Ophthalmol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1186\/1757-1626-2-185","article-title":"A spontaneous suprachoroidal haemorrhage: a case report","volume":"2","author":"Chandra A","year":"2009","unstructured":"Chandra A, Barsam A, Hugkulstone C. A spontaneous suprachoroidal haemorrhage: a case report. Cases J. 2009, 2:185. 10.1186\/1757-1626-2-185","journal-title":"Cases J"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2018.09.005","article-title":"Nutritional supplementation in the treatment of glaucoma: a systematic review","volume":"64","author":"Loskutova E","year":"2019","unstructured":"Loskutova E, O'Brien C, Loskutov I, Loughman J. Nutritional supplementation in the treatment of glaucoma: a systematic review. Surv Ophthalmol. 2019, 64:195-216. 10.1016\/j.survophthal.2018.09.005","journal-title":"Surv Ophthalmol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-9038","article-title":"The association between glaucoma prevalence and supplementation with the oxidants calcium and iron","volume":"53","author":"Wang SY","year":"2012","unstructured":"Wang SY, Singh K, Lin SC. The association between glaucoma prevalence and supplementation with the oxidants calcium and iron. Invest Ophthalmol Vis Sci. 2012, 53:725-31. 10.1167\/iovs.11-9038","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1177\/2040622314530181","article-title":"Dietary factors and the risk of glaucoma: a review","volume":"5","author":"Bussel II","year":"2014","unstructured":"Bussel II, Aref AA. Dietary factors and the risk of glaucoma: a review. Ther Adv Chronic Dis. 2014, 5:188-94. 10.1177\/2040622314530181","journal-title":"Ther Adv Chronic Dis"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/nu9030290","article-title":"Methylsulfonylmethane: applications and safety of a novel dietary supplement","volume":"9","author":"Butawan M","year":"2017","unstructured":"Butawan M, Benjamin RL, Bloomer RJ. Methylsulfonylmethane: applications and safety of a novel dietary supplement. Nutrients. 2017, 9:290. 10.3390\/nu9030290","journal-title":"Nutrients"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000000027","article-title":"Methyl-sulfonyl-methane (MSM)-induced acute angle closure","volume":"24","author":"Hwang JC","year":"2015","unstructured":"Hwang JC, Khine KT, Lee JC, Boyer DS, Francis BA. Methyl-sulfonyl-methane (MSM)-induced acute angle closure. J Glaucoma. 2015, 24:e28-30. 10.1097\/IJG.0000000000000027","journal-title":"J Glaucoma"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/487127-medications-and-supplements-associated-with-drug-induced-glaucoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:16:32Z","timestamp":1780982192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/487127-medications-and-supplements-associated-with-drug-induced-glaucoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.110497","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,8]]}}}